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Background: Aggregatibacter actinomycetemcomitans (Aa) possesses a two-component 
system, QseBC, which is key in biofilm formation/virulence and is activated in the 
presence of iron-catecholamine complexes. Aa does not synthesize enterobactin, a 
catechol-based siderophore, yet possesses the machinery for recognition and uptake. We 
hypothesize that Aa is able to acquire iron by catecholamine mediation through the 
enterobactin receptor/transporter. Methods: By insertional mutation, we attempted to 
delete the enterobactin permease from the genome using suicide vector pJT1. A growth 
curve of truncated mutant ΔfepA was also conducted to observe growth in the presence 
of iron and catecholamines. Statistical significance was determined by ANOVA (p<0.05). 
Results: The permease deletion mutant was not achieved, but the growth curve for 
ΔfepA showed stunted growth in comparison to Wt by 45.4% in a chemically defined 
medium (CDM) supplemented with iron and a 38.4% difference in CDM supplemented 
with iron and norepinephrine. Conclusions: Given the results from the ΔfepA strain we 
can conclude that strains of Aa with mutated enterobactin genes have a reduction in 
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A. Periodontal Disease 
 
There are two main forms of periodontal disease, gingivitis and periodontitis. 
Gingivitis is a mild inflammation of the gums, characterized by swollen, bleeding and 
sometimes painful gingiva with subgingival pocket depths ranging from 4 to 5 mm. With 
proper oral hygiene, gingivitis and its symptoms can be reversed, however, if not treated 
properly it can progress into periodontitis [2]. Periodontitis and eventually severe 
periodontitis is a chronic disease, characterized by damaged soft tissue and supporting 
bone, tooth loss and subgingival pocket depths of 6 mm or more. The main etiological 
agent that causes the periodontal destruction is the buildup of microbial dental plaque.  
Recent studies show that 46% of people aged 30 years or older in the United 
States have some degree of periodontal disease, 8.9% of the adult population suffering 
from severe periodontitis [3]. The prevalence correlated with age and gender and 
occurred more frequently in minorities in comparison to Non-Hispanic whites, displaying 
a variation in occurrence based on socioeconomic position.  
There are several forms of adult periodontitis, from aggressive and chronic 
periodontitis, necrotizing periodontal diseases to periodontitis associated with genetic 
disorders [38].  Many factors come into consideration when classifying chronic versus 
aggressive periodontitis such as age of onset, the rate of disease progression, pattern of 




periodontitis is usually seen in younger patients and spreads at a much faster rate than 
chronic periodontitis normally present in older patients [39].  
Acute and Chronic necrotizing ulcerative gingivitis is usually connected with 
established gingivitis and factors that may influence the host immune response such as 
smoking or drug use [40]. Clinical signs present necrosis of the gingival tissue as well as 
pain and bleeding. Other forms of periodontal disease, for example periodontitis that 
presents itself due to genetic disorders such as Down’s syndrome, is common [41]. 
Morphological, anatomical and immunological aspects all play a role in the progression 
of the disease.  
In 2014 alone, $113.5 billion dollars was spent nationally on dental care, up from 
$112 billion in the previous year [4]. Increasing awareness of oral health and advocating 
positive oral hygiene could alleviate some of the expenditure. In addition to the great 
expenses for dental care in the United States, there is evidence linking periodontal disease 
to the onset of other systemic disorders and life-threatening conditions such as 
atherosclerosis, osteoporosis, rheumatoid arthritis, diabetes and pregnancy complications 
such as preterm birth [5]. These systemic diseases will only add to the increasing cost of 
healthcare around the world and signifies the importance of reducing the spread of 
periodontal disease in the human oral cavity.  
One of the main causes of the onset of periodontal diseases is the buildup of 
microbial plaque. If the biofilm of bacteria is not limited by mechanical means or the 
naturally occurring antimicrobial activity of saliva, biofilm growth can spread to the 
subgingival pocket. The development of a biofilm begins almost as soon as the tooth 




prevent continuous deposition of calcium phosphate from the saliva and permits the 
attachment of early colonizing bacteria such as the oral streptococci [11]. Eventually, 
other microbes attach to the foundation of the biofilm already created by early colonizers. 
Coaggregation begins with successive colonization by bacteria such as Actinomycetes, 
Prevotella, Eikenella, and Fusobacterium nucleatum [12]. These communities of 
commensal and pathogenic bacteria reside on the teeth and are shielded and protected 
from antimicrobial salivary proteins and enzymes by the biofilms they create. In healthy 
plaque, pathogenic bacteria are usually found in relatively low numbers until some 
environmental stimuli triggers an expansion of their populations and expression of their 
virulent factors. The expression of virulence factors is hypothesized to be attributed to an 
imbalance of bacteria in the oral microbiome, or dysbiosis. This microbial shift is similar 
to an overgrowth of bacteria such as H. pylori in the gut leading to conditions like 
gastritis and peptic ulcers. Likewise, a flux of the oral bacteria residing in the oral cavity 
from mostly gram-positive aerobes to gram-negative anaerobes increases chances of 
disease [34]. Although P. gingivalis has been isolated from healthy oral cavities [34], its 
presence is usually found when the oral microbiome has shifted to an anaerobic 
environment where it causes the most damage [35]. Indeed, P. gingivalis has even earned 
the title of a ‘Keystone’ pathogen for its primary role in conditions surrounding 
periodontal diseases.  Ultimately, expansion of the biofilm in the subgingival pocket 
induces an inflammatory response and immune cells such as neutrophils and 
macrophages migrate to the site of infection. Eventually, osteoclasts are stimulated either 
by the presence of the invading anaerobic bacteria or primarily by the immune response 




of the periodontal ligament and other tissues [31]. Pro-inflammatory cytokines released 
from responding immune cells activate osteoblasts to discharge osteoclastic factors such 
as IL-1, IL-6, and TNF [6]. Furthermore, components found in the outer membrane of 
gram-negative bacteria called lipopolysaccharide (LPS) and endotoxin proteins of 
bacteria are pro-inflammatory [6,7]. For example, the fimbriae of P. gingivalis stimulate 
the synthesis of chemotactic and osteolytic cytokines from monocytes and fibroblasts 
[8,9,10]. The functional consequences of both host and microbial factors cause resorption 
of the alveolar bone, leading to bone and tooth loss. There are many pathogenic bacteria 
associated with chronic adult periodontitis that also include Treponema denticola, 







Figure 1. Representation of Oral Biofilm. From J.M.F.A. Fernandes, V.A. Menezes, A.J.R. 
Albuquerque, M.A.C. Oliveira, K.M.S. Meira, R.A. Menezes Júnior and F.C. Sampaio (2015). 
Improving Antimicrobial Activity of Dental Restorative Materials, Emerging Trends in Oral Health 






B. Aggregatibacter actinomycetemcomitans 
In 1996, a number of bacteria including A. actinomycetemcomitans were 
designated as etiological agents of periodontitis [15]. Aa is a non-motile, gram-negative 
facultative anaerobe of the Pasteurellaceae family that is commonly found in the 
microbial community of the human oral cavity and indeed exists as a commensal in many 
individuals. There are six serotypes of A. actinomycetemcomitans denoted from serotype 
‘a’ to serotype ‘f’, with the distribution of affliction depending on the geographic 
location. For example, a study conducted in 1998 showed that patients in the United 
States displayed significantly higher levels of antibodies to the ‘b’ serotype of A. 
actinomycetemcomitans compared to Turkish patients, who showed significantly higher 
levels of anti-bodies to the ‘c’ serotype [16]. Recently, a study conducted in the United 
States in 2010 observed all serotypes in the oral cavities of the participants, in varying 
distributions [36]. Serotype ‘c’ was the dominant serotype, followed by ‘a’ and ‘b’. 
Serotypes ‘d’ and ‘e’ were rare, while the prevalence of ‘f’ is still under investigation 
[37]. Additionally, patients may harbor just one serotype, or several  [36].  
A. actinomycetemcomitans is associated with a form of periodontal disease known 
as localized aggressive periodontitis (LAP), a disease that affects adolescents, more so in 
minority populations [16,17]. In patients of African descent LAP has been shown to be 
linked to a lineage of the b serotype, also known as the JP2 clone, which possesses a 
deletion in the leukotoxin promoter leading to increased leukotoxin production and 
variations in the mechanism for iron acquisition. Interestingly, this suggests that multiple 




by non-JP2 A. actinomycetemcomitans functioning as an opportunistic pathogen as seen 
in European Caucasian populations [16, 18]. What specifically triggers A. 
actinomycetemcomitans to exhibit pathogenic characteristics is unclear, but evidence is 
beginning to show that the presence of other oral bacteria enhances the virulence of A. 
actinomycetemcomitans [15]. In fact, studies have shown heightened growth and 
resistance to the host immune response in A. actinomycetemcomitans by the presence of 
streptococcus strains, such as S. gordonii [28]. Its ability to resist the host immune 
response can partly be attributed to the hydrogen peroxide (H2O2) that is produced by the 
streptococci. The presence of H2O2 that is produced as a waste product from the 
streptococci induces expression of genes katA and apiA. The gene katA aids in detoxing 
the H2O2 into oxygen and water, while apiA boosts auto-aggregation, host cell invasion 
and binds to human serum protein factor H which protects A. actinomycetemcomitans 
from the complement pathway system [28].  
Additionally, A. actinomycetemcomitans secretes a leukotoxin (LtxA), which is a 
member of the repeats-in-toxin (RTX) family that specifically target the β(2)-integrin 
leukocyte function antigen-1 (LFA-1) that is expressed by white blood cells [30]. The 
targeting of this protein leads to apoptosis, or programmed cell death of the white blood 
cells. This is accomplished by the internalization of LtxA after binding to LFA-1, where 
LtxA is brought to the lysosome. The lysosomal membrane is then disrupted by the 
leukotoxin and the lysosomal contents are released into the cytoplasm, killing the cell 
[30].     
Other virulence factors that allow A. actinomycetemcomitans to reside in the oral 




population present different forms of fimbriae, transparent rough, transparent smooth and 
opaque [15]. Transparent rough and smooth fimbriae are able to bind to surfaces such as 
agar and glass, while the opaque cannot. Antibodies to synthetic A. 
actinomycetemcomitans fimbriae blocked binding to saliva-coated surfaces including 
buccal epithelial cells displaying the important role fimbriae play in colonizing a host 
[15]. Isolating the fimbriae exposed a protein named Flp that was part of a larger open 
reading frame that when analyzed revealed a protein structure similar to type IV pili [15]. 
Clinical isolates of A. actinomycetemcomitans display large fibrils branching off the 
organism, which are removed after passaging. These large fibrils resemble the bundle-
forming fimbriae present on enteropathogenic E. coli, the branching fimbriae cause auto-
aggregation of A. actinomycetemcomitans [15]. Aggregation of the bacteria allows for 
resistance to salivary flow and maintains the presence of the bacteria in the oral cavity.  
Other virulence factors responsible for host colonization include the presence of adhesin 
proteins on the outer-membrane that mediate cell invasion [15]. Many bacteria possess a 
receptor for fibronectin, a glycoprotein of the extracellular matrix of host cells that binds 
to components such as collagen, and are able to invade cells by receptor-mediated 
endocytosis [20].  
There are many factors that allow A. actinomycetemcomitans to reside and be 
maintained in the oral microbiome, including the two-component system QseBC. 
C. Two-Component System (QseBC) 
 In order for bacteria to be able to survive in the oral cavity, organisms need to 
quickly respond to the local environment that can be in constant flux. One factor that 




system, comprised of a two-component system designated QseBC (Figure 2). QseBC 
consists of histidine kinase QseC, which is comprised of a periplasmic sensor domain, 
two trans-membrane domains and a kinase domain located in the cytoplasm. Binding of 
the signal by QseC activates the kinase domain and initiates a cascade that results in the 
phosphorylation of QseB. QseB responds to the activation of QseC via a receiver domain 
and a helix-turn-helix DNA binding motif, which in turn influences gene expression 
(Figure 2) [21].  
 Different bacteria possess QseBC and rely on its role in virulence [35]. Studies 
have shown that QseBC in E. coli is activated by the presence of catecholamines [22]. 
This activation leads to increased expression of genes responsible for biofilm growth, the 
expression of flagella and motility as well as other virulence genes [21]. Furthermore, 
QseBC expressed by H. influenzae responds to ferrous iron, but not catecholamines [23].  
A. actinomycetemcomitans is unique in that QseBC may be activated by the 
presence of iron-catecholamine complexes. Strains of A. actinomycetemcomitans lacking 
QseC showed altered phenotypes compared to the wild-type strain, such as significantly 
lowered levels of biofilm mass [25] and a reduced capacity of inducing bone loss in a 
mouse model of periodontitis [35].  
Catecholamines such as norepinephrine or epinephrine act as pseudosiderophores 
and are able to strip iron away from host iron-containing proteins such as lactoferrin and 
transferrin [24]. Indeed, the role of transferrin is to deliver iron to iron-dependent cells 
throughout the body via the circulatory system [19]. Transferrin and lactoferrin are also 
associated with the innate immune system. As a result of the high affinity for iron, 




body, making it inaccessible to bacteria. However, the presence of stress hormones in 
response to inflammation such as gingivitis may result in an environment that is rich in 
catecholamines. Since lactoferrin is also released by neutrophils, bacteria may then be 
able to utilize these stress hormones to acquire an essential nutrient via by catecholamine-
mediated iron acquisition.  
In order to acquire iron, bacteria secrete siderophores into the extracellular space 
of their environment. Siderophores have a high affinity towards iron and bacteria are able 
to transport the iron into the cell once the siderophore receptors on the outer membrane 
recognize the complex. E. coli and other enteric bacteria utilize the siderophore 
enterobactin. Studies have shown that enterobactin is vital as the final acceptor of iron 
from iron-catecholamines complexes [26]. Mutant strains of E. coli defective in either 
enterobactin synthesis or siderophore uptake were placed in the presence of transferrin 
and norepinephrine. Results showed significant decreases in iron uptake, indicating that 
enterobactin is required for obtaining iron from catecholamines [24,26]. When the 
mutations were complemented back into the bacteria, the ability to accept iron stolen 
from transferrin in the presence of norepinephrine was restored. Additionally, research 
showed the shuffle of iron from loaded transferrin to unloaded transferrin in the presence 
of norepinephrine, supporting that the catecholamines are able to stimulate shuffling of 












Figure 2. TCS QseBC. From Weigel, W.A. and Demuth, D.R. QseBC, a two-component bacterial 
adrenergic receptor and global regular of virulence in Enterobacteriaceae and Pasteurellaceae. Mol 
Oral Microbiol. 2016. 31(5): p. 379-397. 
 
D. Enterobactin Operon  
 Interestingly, A. actinomycetemcomitans does not synthesize enterobactin, a 
catechol-based siderophore, yet possesses an enterobactin operon that codes for the 
recognition and uptake of it. This may suggest that A. actinomycetemcomitans has 
evolved to be an opportunistic pathogen, taking advantage of the host environment. With 
the evidence that QseBC is activated in the presence of iron-catecholamine complexes 
and the possession of enterobactin machinery for the uptake of enterobactin, this raises 
the question of the relationship between the enterobactin operon and stress hormone 
mediated iron acquisition. 
The enterobactin operon consists of six genes, encoding proteins that make up the 




encoded on the operon is an iron ABC-family transporter. Specifically, the first operon 
gene, annotated as 1357 of serotype c D11S-1 codes for a solute-binding protein of the 
ABC transporter, D11S_1356 codes for the permease protein and D11S_1355 codes for 
an ATP-binding protein. The enterobactin ABC transporter for bacteria that synthesize 
the siderophore is important for transport of iron into the cell. ABC transportation is a 
form of active transport, which requires adenosine triphosphate (ATP) to translocate 
solutes across the cell membrane. The solute is then imported through a transmembrane 
protein permease from the periplasm to the cytoplasm.  
Genes D11S_1354 codes for a TonB-dependent outer membrane siderophore 
receptor protein designated as fepA. This receptor is present on the outer membrane of 
gram-negative bacteria and is a member of the beta-barrel protein family. FepA is an 
essential outer membrane porin protein that is involved in the import of iron from the 
extracellular space to the periplasm of gram-negative bacteria, mediated by siderophores.  
Thus the flow of iron acquisition is the recognition of ironbound enterobactin by outer 
membrane receptor FepA, which brings the molecule into the periplasm where it is 
recognized by the ABC transporter and transported into the cytoplasm.  
 
 
Figure 3 [42]. Enterobactin Operon. From Weigel, Whitney, "Functional characterization of 
Aggregatibacter actinomycetemcomitans QSEBC : a bacterial adrengeric receptor and global 







E. Significance   
 Microbial endocrinology is an emerging field in which the relationship between 
bacterial organisms and host hormones present during infection are observed [27]. When 
the body is under some kind of stress, like the inflammation that occurs during 
periodontal disease, stress hormones are released. Stress stimulates the release of 
neurotransmitter catecholamines like epinephrine or norepinephrine by the sympathetic 
nervous system, putting the body in the “flight or fight” state.  
 The combination of the release of stress hormones and the immune response puts 
bacteria in a perfect position to take advantage of the environment. As cells associated 
with the immune system, e.g., neutrophils, respond to the area of infection, additional 
stress hormone and iron-chelating molecules are released. Thus the presence of both 
stress hormone and iron-complexes allow for catecholamine mediated iron acquisition for 
any inhabiting bacteria, benefiting from both the stress and immune response.  
 As previously stated, although A. actinomycetemcomitans does not synthesize the 
siderophore enterobactin, it does encode the transportation system for recognition and 
uptake of the molecule. There is also evidence that the two-component system QseBC is 
activated in the presence of iron-catecholamine complexes, leading to an induction of 
genes responsible for anaerobic metabolism and respiration and a down regulation in 
genes encoding iron acquisition [21]. This is possibly a result of the bacteria sensing an 
iron rich environment and spends less energy in trying to bring in large amounts of iron.  
The importance of QseBC in virulence and the ability of pseudosiderophores may 
suggest that A. actinomycetemcomitans has evolved to utilize stress hormone mediated 




the hypothesis of this thesis is that A. actinomycetemcomitans acquires iron by stress 

















































PART I: INSERTIONAL MUTAGENESIS 
 To study the role between the enterobactin operon, the acquisition of iron and its 
possible influence on the expression of QseBC, mutant strains of Aggregatibacter 
actinomycetemcomitans (Aa) lacking genes responsible for iron acquisition were 
analyzed. Specifically, studies will observe strains of Aa with inhibited outer membrane 
receptor FepA or deletion of the intermembrane permease.  
A. Preparation  
Stocks of Aggregatibacter actinomycetemcomitans wild-type strain 652 serotype ‘c’ 
were grown overnight in 50 mL of Brain Heart Infusion medium (BHI: 37g BHI powder 
per liter, pH 7.4 ± 0.2), pelleted, resuspended in 1 mL BHI and 1 mL glycerol and stored 
in a -80°C freezer.  Wild-type strain 652 was grown in 10 mL brain heart infusion 
overnight and genomic DNA was obtained from the culture via Promega ‘DNA 
Purification System Miniprep’ following the manufacturer’s protocol. The insertional 
mutation was carried out using the suicide vector pJT1 (Figure 4). Strains of XL1-Blue 
Escherichia coli, electrocompetent cells containing the plasmid pJT1, were grown 
overnight in 50 mL Luria Bertani medium (25g LB powder per liter, pH 7.0 ±0.2) and 
stored in a -80°C freezer. To acquire the plasmid, the pJT1 containing E. coli were 
inoculated into 10 mL LB and placed in an incubated shaker overnight at 37°C. The 




Miniprep Kit’ by Qiagen following the provided protocol. Both A. 
actinomycetemcomitans genomic DNA and pJT1 are rehydrated with nuclease free water 
and stored in a 4°C refrigerator.  
B. Polymerase Chain Reaction (PCR)  
Standard polymerase chain reactions were carried out via the use of Radiant ‘HiFi 
ultra DNA Polymerase’ following the protocol provided using the BioRad Mycycler 
Thermal Cycler. This was used to amplify the flanking genes (D11S_1357 and 1355) of 
the enterobactin permease (D11S_1356) of the Genomic DNA of A. 
actinomycetemcomitans D11S strain. The primers used in the reaction are listed in the 
table below.  
Table 1. PCR Primer Sets 
Primer Name Sequence 5’- 3’ 
TJ24 (F*) GGAAATTCCCATGGCGGCCGCAAAAAAT
GG 





  *F denotes Forward Primer; R denotes Reverse Primer; underlines portions             















The PCR reaction mix was as follows:  
- 10µL Radiant 5X HiFI Ultra Reaction Buffer 
- 2µL Forward Primer (10µM) 
- 2µL Reverse Primer (10µM) 
- 1µL gDNA  
- 0.5uL Radiant HiFi Ultra Polymerase (2u/µL) 
- 34.5µL PCR-grade water 
The following table displays the PCR program settings:  
Table 2. PCR Settings. 
Cycles  Temperature  Time Notes 
1 95°C 1 minute Initial Denaturation 
25-35 95°C 









The PCR product was observed by gel electrophoresis, purified using a PCR clean 
up kit and stored in a 4°C refrigerator.  
Gel Electrophoresis Preparation:  
1% agarose gel was prepared by dissolving 1 gram of molecular biology grade 
agarose powder in 100 mL of 1X Tris-acetate-EDTA (TAE) buffer. The mixture was 
heated in a conventional microwave until all agarose powder has melted into solution. It 
was allowed to cool before adding 5 µL of Midori Green Advance DNA stain. Once the 
gel had set, the gel was carefully transferred to an electrophoresis chamber (1X TAE 
buffer). 10 µL of 1KB ladder (Figure 4) was then added to the first well to help quantify 




subsequently added to the neighboring wells. A current was applied to the chamber 
(≅100V) for 50 minutes and visualized under UV light.  
C. Digestion  
 Amounts of up to 1 µg of PCR product were used for the digestion process. Digestions 
occur to make specific cuts along the genomic DNA and plasmid pJT1 DNA for ligation 
later in the experiment using specific restriction enzymes. The upstream and downstream 
PCR product portions and pJT1 are digested with the appropriate restriction enzymes 
based upon the flanking genes (D11S_1357 and D11S_1355) and the MCS portion of 
pJT1 (Figure 14) and incubated at 37°C overnight. To prevent self-ligation of the plasmid 
during the ligation phase, terminal 5’-phosphate groups are removed by a phosphatase 
and incubated at the same temperature for an additional hour.  
Table 3. Digestion Set-up. 
Digestion 1 Digestion 2 Digestion 3 
X µL TJ24+25 X µL TJ26+27 X µL pJT1 
1 µL NotI 1 µL XhoI 1 µL NotI 
1 µL XhoI 1 µL PstI 1 µL PstI 
10% total vol. Buffer 3.1 10% total vol. Buffer 3.1 10% total vol. Buffer 3.1 
Remaining µL H2O Remaining µL H2O Remaining µL H2O 
= Total µL = Total µL = Total µL 
X is determined by ng/µL  
Nucleic acid quantitation was determined by a nanodrop spectrophotometer 
machine and used to calculate the amount of the digestion product used for the ligation 
portion of the experiment. Following the clean up of the digestion product, the three 




Figure 5. Plasmid pJT1. From Juárez-Rodríguez MD, Torres-Escobar A, Demuth 
DR. Construction of new cloning, lacZ reporter and scarless-markerless suicide 
vectors for genetic studies in Aggregatibacter actinomycetemcomitans. Plasmid, 2013. 




 The equation below was used to calculate the amount from each of the digestion 
products needed for the ligation. It is used to determine the amount of each digestion 
product needed (X ng) for successful ligation:  
  X = (10ng vector)(bp insert)/(3.8bp pJT1)  
Once the amount needed was calculated, the three samples were then added 
together in a microcentrifuge tube, incubated at 55°C for 5 minutes and T4 ligase, T4 
ligase buffer and water were then added to the mixture. The ligation was placed in a 4°C 
refrigerator for at least 48 hours.   
 
replication or selection. To validate its utility as shuttle
cloning vector, the A. actinomycetemcomitans lsrRK operon
and crp gene were cloned individually into pJT4 (see Sec-
tion 2) and the resulting recombinant plasmids pATE52
and pATE60, respectively, were selected for in E. coli and
analyzed by restriction digestion. Subsequently, these plas-
mids were introduced by electroporation into A. actinomy-
cetemcomitans 652, re-isolated from recombinant cells and
shown to be identical to the input plasmid by restriction
analysis (data not shown). These results confirm that the
pJT4-derivative plasmids replicate and are maintained in
both E. coli and A. actinomycetemcomitans cells. Finally,
the lacZ gene from pBAD-lacZ was introduced into pJT4
resulting in the transcriptional/translational reporter plas-
mid pJT5 (Fig. 3C). To demonstrate the utility of pJT5, the
255 bp A. actinomycetemcomitans lsrR promoter was cloned
into the plasmid to generate pATE65. pATE65 was intro-
duced by electroporation into A. actinomycetemcomitans
652 and b-galactosidase activity produced by this strain
was compared to a similar strain harboring pATE12
(pYGK-lacZ fused to the lsrR promoter) and pATE23 (pJT3,
lsrR promoter-lacZ) (Torres-Escobar et al., 2013). The lsrR
promoter expressed similar levels of activity (see Table 4),
indicating that pJT5 functions as a transcriptional/transla-
tional reporter plasmid for studies of gene expression in
A.actinomycetemcomitans. Plasmid pJT3, pJT4, pJT5 and
pJT6 were stably maintained for 50 or more generations
in A. actinomycetemcomitans under selective conditions
and A. actinomycetemcomitans transformant cells [OD600nm
of 0.6 (1.15 ! 109 colony forming, CFU, units ml"1)] pro-
duced the same amount of each recombinant plasmid
(#0.75 g ml"1) as pYGK (not shown). pJT4 and pJT5 are
both almost 2 kbp smaller than the pYGK plasmids from
which they were derived.
3.4. pJT1, a scarless-markerless suicide plasmid
The suicide plasmid pJT1 (Fig. 3D) carries the pUC origin
of replication and does not replicate in A. actinomycetem-
comitans. In addition, pJT1 is a sucrose-sensitive suicide
vector containing the Bacillus subtilis sacB gene encoding
levane saccharase. This gene is lethal in most Gram-nega-
tive bacteria in the presence of sucrose (Gay et al., 1983)
and thus provides strong selection for isolation of
Fig. 3. Physical maps of transcriptional/translation reporter plasmid pJT3 (A), the cloning vector pJT4 (B), the transcriptional/translation reporter plasmid
pJT5 (C) and the suicide vector pJT1 (D).
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E. Electroporation  
 The ligation mix was then electroporated into 50 µL electrocompetent E. coli 
using the BioRad ‘Micropulser’ on the setting ‘EC1’ in a 0.1 cm cuvette (1.8kV). The 
cells were quickly nourished with 500 µL of Super Optimal broth with added Catabolite 
repression (SOC, see Table 4 below) and placed in a shaking incubator at 37°C for one 
hour. After incubation, the culture was then distributed to LB/spectinomycin agar plates 
in 3 µL droplets and incubated at 37°C for 24 hours.  
Table 4. Stock Solution of 1X SOC Media. 
Amount Compound Concentration 
100 µL NaCl 5M 
125 µL KCl 1M 
500 µL MgCl2 1M 
500 µL MgSO4 1M 
1 mL Glucose 1M 
 
F. Plasmid Extraction  
 Spectinomycin resistant E. coli colonies were collected individually and grown 
over night in 10 mL of LB supplemented with 10 µL of spectinomycin. The complete 
plasmid construct was isolated by using the Qiagen ‘Spin Miniprep Kit’, nucleic acid 
quantitation was determined by nanodrop and stored in a 4°C refrigerator. To verify that 
the correct cuts were made during the digestion phase of the experiment, an additional 
digestion was carried out to identify both the plasmid pJT1 and the two flanking gene 
fragments of genes D11S_1357 and D11S_1355. To do so, 1 µg of each plasmid was 







































1 µL NotI 1 µL NotI 1 µL NotI 1 µL NotI 1 µL NotI 1 µL NotI 1 µL NotI 





































G. Sequencing  
 Using the same conditions referenced in part B; gel electrophoresis is conducted 
with the samples and observed under UV light. Samples showing DNA bands at both 3.8 
KB (indicating pJT1) and 1400 base pairs (indicating fragments TJ24/25 and TJ26/27) 
were selected and prepared for sequencing. For sequencing, 400 ng of the plasmid were 
prepared as well as primer for the DNA sequencing process, MDJR 263.  
Table 6. Set-up for Plasmid Sequencing 
Sample  
400 ng Construct 




= 12 µL Total 
	
	 Data from The Center for Genetics and Molecular Medicine Sequencing Service 
of the University of Louisville will suggest whether or not there was successful ligation 
of plasmid pJT1 and genomic DNA of A. actinomycetemcomitans by identifying specific 
genomic sequences unique to the flanking genes D11S_1357 and D11S_1355 and the 




prepared for storage and stocked in an -80°C freezer.  
H. Electroporation of Plasmid Construct into A. actinomycetemcomitans  
 Plasmid pJT1 was isolated from the strains of E. coli containing the complete 
construct using the Qiagen ‘Spin Miniprep Kit’ following the protocol provided by the 
manufacturer. Amounts of up to 20 µg of the plasmid were electroporated into competent 
A. actinomycetemcomitans using the BioRad ‘Micropulser’ on the setting ‘EC1’ in a 0.1 
cm cuvette (1.8kV). The cells were then quickly nourished with 500 µL of SOC media 
(Table 4), incubated at 37°C for one hour under anaerobic conditions and distributed onto 
a BHI/Spectinomycin agar plate in 3 µL droplets. 48 hours later, spectinomycin resistant 
colonies were collected, grown overnight in 50 mL of BHI supplemented with 
spectinomycin, prepared for storage and stocked in a -80°C freezer.  
I. Passaging  
 Successfully electroporated A. actinomycetemcomitans will present 
spectinomycin resistant growth. To verify successful integration, the genomic DNA of a 
colony was analyzed with diagnostic primers (Table 7) via PCR (Figure 8). 
Spectinomycin resistant Aa was inoculated into 1 mL of BHI supplemented with 1 µL of 
spectinomycin and incubated overnight at 37°C. The following day, 5 µL was taken from 
the overnight culture, placed into a fresh microcentrifuge tube containing the 
BHI/Spectinomycin and incubated overnight. The next 3 days, 5 µL was taken from each 
previous passage and passaged into just 1 mL of BHI and incubated overnight. After the 
third passage in BHI, 5 µL was passaged into 1 mL of Tryptone Yeast Extract (TYE) 
broth and the process was repeated for the next 3 days. On the ninth day, 5 µL was taken 




Isopropyl β-D-1-thiogalactopyranoside (IPTG). IPTG induces the transcription of the 
sacB gene of pJT1, which encodes levanesucrase. Levanesucrase is lethal to gram-
negative bacteria. Any growth after the addition of IPTG provides a strong selection for 
A. actinomycetemcomitans cells that have undergone double recombination to eliminate 
sacB. To select the bacteria that have undergone this double recombination, cultures were 
diluted to 1x10-5 the original amount and streaked onto TYE/1% IPTG/40% sucrose agar 
plates and incubated at 37°C under anaerobic conditions for 48 hours.  
J. Double Recombinant Selection  
 Sucrose resistant colonies were replica plated onto to TYE/1% IPTG/40% 
Sucrose agar plates and BHI/Spectinomycin agar plates. The purpose of doing so was to 
confirm and select the desired phenotype observed on the primary plate, in this case 
sucrose resistant/spectinomycin sensitive Aa colonies. The plates were incubated again 
for 48 hours at 37°C under anaerobic conditions. Sucrose-resistant/spectinomycin 
sensitive colonies were collected, grown overnight in 10 mL BHI, prepared for storage 
and placed in a -80°C freezer.  
 Colonies were grown overnight in 1 mL of BHI, centrifuged and resuspended in 1 
mL of purified water three times to obtain usable genomic DNA of any potential mutant. 
The PCR conditions were similar to the protocol described in part B, however the initial 
denaturation phase is increased to two minutes to verify cell lysis of the colony samples 
obtained. 
Colony PCR:  
- 2 µL Colony gDNA 




- 2 µL M6 (R) 
- 10 µL Radiant 5X HiFI Ultra Reaction Buffer 
- 0.5 µL Radiant HiFi Ultra Polymerase (2u/µL) 
- 33.5 µL Water 
The PCR products were observed under UV light after gel electrophoresis (same 
conditions as part B). Diagnostic primers were created to observe the possibility of the 
deletion of gene D11S_1356. Forward primer M7 began shortly upstream of the original 
upstream fragment of D11S_1357 and reverse primer M6 began shortly downstream of 
the original downstream fragment of gene D11S_1355. The wild type strain should show 
a size of around 2800 base pairs, any colony PCR that resulted in a reduced size indicates 
a mutation and will be collected, grown up overnight in BHI and stocked in a -80° freezer.  
Table 7. Diagnostic Primers 
Primer Name Sequence 5’-3’ 
M7 (F) GACGATTTTGCACCCGAAGTGCAA 
M6 (R) GGTGCAAATAAATCTTCTAAAAACACAAATGCC 
 
PART II 
WT/ΔFEPA GROWTH STUDIES 
 Outer membrane receptor, FepA, recognizes iron in the extracellular spaces and 
imports the resource into the periplasmic space of Aggregatibacter 
actinomycetemcomitans. Observing the effects on the growth of ΔfepA strains of Aa in an 
environment supplemented with iron and stress hormone may support the hypothesis of 
the role of the enterobactin operon in iron acquisition.  
A. Preparation 




overnight at 37°C under anaerobic conditions. They were then centrifuged, resuspended 
in 1 mL BHI/1 mL glycerol and stored in a -80°C freezer.  
B. Growth Study 
 Twelve 50 mL conical tubes will be prepared for each strain with triplicates of 
each of the four conditions. The four conditions are: CDM, CDM supplemented with 100 
µM ferrous chloride, CDM supplemented with 50 µM norepinephrine, and CDM 
supplemented with both 100 µM ferrous chloride and 50 µM norepinephrine. Each 
conical tube will receive 200 µL of the appropriate strain of A. actinomycetemcomitans, 
20 µL of 100 µM ferrous chloride into each tube that requires iron and 20 µL of 50 µM 
norepinephrine into each tube that calls for catecholamine.   
 The growth of each strain of A. actinomycetemcomitans in each of its conditions 
was checked at 4, 12, 24, 36, and 48 hours by a spectrophotometer at wavelength of 600 
nm. To do so, 4 mLs from each conical tube was taken and placed into a 10 mL conical 
tube, centrifuged and resuspended in 1 mL of BHI. The bacterial concentrations were 
then measured at a setting of OD600. Each of the triplicates from the two strains in their 
four conditions were compared to a blank of 1 mL BHI. The data for each triplicate was 
averaged and compared to the other strain.  
C. ΔFepA Growth With Transferrin 
 Wild type and ΔfepA strains of A. actinomycetemcomitans were grown over night 
in 10 mL of BHI, centrifuged and resuspended in 10 mL of CDM. Both strains of A. 
actinomycetemcomitans were inoculated into a solution of CDM and 100 µM/mL holo-
Transferrin (1,200 – 1,700 ppm iron content) and CDM supplemented with both 100 µM 




Each well will receive 1 mL of each environment for both wild type and ΔfepA strains of 
A. actinomycetemcomitans, in triplicate. Readings were taken by a plate reader and 
incubated at 37°C under anaerobic conditions and observed at 4, 12, 24, 36, and 48 hours.  
E. Apo-Transferrin Control 
 Wild type and ΔfepA strains of A. actinomycetemcomitans were grown over night 
in 10 mL of BHI, centrifuged and resuspended in 10 mL of CDM. Both strains of A. 
actinomycetemcomitans were inoculated into a solution of CDM and 100 µM apo-
Transferrin (<0.005% iron content) and CDM supplemented with both 100 µM apo-
transferrin and 50 µM norepinephrine. A 48-well plate was used to harbor the bacteria, 
each well receiving 1 mL of each environment for both wild type and ΔfepA strains, in 
triplicate. The 48-well plate was incubated at 37°C under anaerobic conditions and 




















PART I: INSERTIONAL MUTATION 
The first step in constructing the pJT1 construct was amplifying the flanking 
genes of the gene of interest, D11S_1356, by PCR. Following the PCR protocol using Aa 
gDNA template and designed primers, the concentration of the PCR product after 
purification was: TJ24 + TJ25 = 207.3 ng/µL (Figure 5); TJ26 + TJ27 = 106.3 ng/µL 
(Figure 6).  










    
 
Figure 8. Downstream PCR Product (≈850 bp) 
 
 
Figure 9. Representation of Downstream PCR Amplification 
 
Following the PCR process, pJT1 and the PCR products were digested with 
specific restriction enzymes, which make cuts in targeted sequences of the DNA. 
Amounts of up to 1 µg of PCR product were digested with the restriction enzymes NotI 
and XhoI for the upstream region amplified by primers TJ24,25 and XhoI and PstI for the 
downstream region amplified by primers TJ26,27. A 1µg concentration of pJT1 was also 
used and digested with restriction enzymes NotI and PstI. This proposes two possible 
insertion points of plasmid pJT1 once the products are ligated together, pJT1 inserted into 
either upstream gene D11S_1357 or downstream gene D11S_1355.  
Results from the digestion process were computed into the equation used for 






concentration of the digestion product of pJT1 was 37.4 ng/µL. Taking 1µL of the 
digestion into 3.74 µL of water diluted it to 10ng/µL. The fragment of TJ24,25 was a size 
547 base pairs, which computed a 1.44 ng requirement. To increase the chances of a 
successful ligation, a high flanking region to plasmid ratio was used. Any concentration 
up to a 100:1 ratio that did not result in successful ligation would require repeating the 
PCR and digestion processes, even redesigning PCR primers. The concentrations 
obtained allowed for up to an 80:1 ratio and thus, 4.88µL (115 ng) of Digestion 1 was 
taken for the ligation. Likewise, the fragment of TJ26,27 was 856 base pairs, computing a 
2.25 ng requirement. Again, an 80:1 concentration was used, calculating to 6.29 µL 
(179.89 ng) of Digestion 2 for ligation.   
The components were combined to give a total volume of 15 µL as follows: 
- 80:1 TJ24+25 4.88 µL 
- 80:1 TJ26+27 6.29 µL 
- 1:3 pJT1 1 µL 
- T4 DNA Ligase 0.8 µL 
- T4 DNA Ligase Buffer 1.5 µL 
- Water 0.53 µL 
The ligation was electroporated into competent E. coli plated onto LB/spec agar 
plates where seven colonies grew, indicating successful integration. Plasmid pJT1 is not 
suicidal in E.coli and allowed for quantities of the construct to be accumulated and 
stored. The plasmids that were isolated from the spectinomycin resistant colonies were 
re-digested with the upper restriction enzyme used, NotI, and the lowermost restriction 




that were made in the primary digestion. The product of this digestion was then observed 
under UV light. 
Figure 10. Construct Observation 
  
 
The upper DNA marker displays the appropriate genomic quantity for plasmid 
pJT1 at 3,800 nucleotide base pairs. Of the seven samples, samples numbers 2 and 4 
(table 10) were identified displaying insert fragments consistent with the anticipated 
DNA insert of around 1,400 base pairs. These constructs were prepared and sent for 
sequencing. The data received from the sequencing department identified the upstream 
and downstream fragments D11S_1357 and D11S_1355, suggesting a successful ligation 
with plasmid pJT1.  
This construct was then electroporated into electrocompetent A. 
actinomycetemcomitans resulting in five spectinomycin resistant colonies, indicating a 
single recombination. Genomic DNA of the spectinomycin resistant colonies was 
obtained using Promega ‘DNA Purification System Miniprep’ and diagnostic primers 
were used to sequence the DNA within the parameters (Table 7). The PCR identified 
both the D11S_1357/1355 fragment at approximately 1,400 base pairs, and the 








Figure 11. Colony PCR After Integration Displaying Host Chromosome and 
Construct. 
55 .  
 
These colonies then began the passaging phase to select for the colonies that had 
undergone a double recombination by presence of growth in sucrose. The colonies that 
grew in the presence of sucrose were diluted and plated on a TYE/IPTG/40% sucrose 
plate. After incubation, the colonies that grew were replicate plated onto another 
TYE/IPTG/40% sucrose plate and a BHI/spectinomycin plate. Again, after incubation, 48 
colonies that expressed spectinomycin sensitivity and sucrose resistance were collected 
[insert picture]. The diagnostic primers M6 and M7 were used (Table 7), with the forward 
primer M7 shortly upstream of the original upstream fragment and the reverse primer M6 
shortly after the original downstream fragment to verify that gene D11S_1356 had been 
deleted. However, colony PCR had revealed the same DNA amount as the wild type, 







Figure 12.  Colony PCR Post Passaging Process, Displaying Wt DNA Size (≈2800 
bp) 
.   
 
To determine whether the plasmid had been maintained in these clones, sucrose 
resistant colonies were grown in BHI supplemented with spectinomycin. Interestingly, 
growth did occur, meaning that spectinomycin resistance was being retained in these 
strains of A. actinomycetemcomitans. A plasmid miniprep was conducted, resulting in a 
low concentration of 10 ng/µL of plasmid. To verify that the plasmid pJT1 had not 
mutated, the same stock used in the ligation process above and a new stock of pJT1 was 
electroporated into competent A. actinomycetemcomitans. Indeed, no growth occurred, 
which verifies that the plasmid pJT1 had not been altered before its electroporation into 








PART II: Wt/ΔfepA Growth Study 
Although Δpermease strains of A. actinomycetemcomitans were not obtained, this 
study was intended to help answer the question of the relationship between the 
enterobactin operon and the presence of iron-catecholamine complexes. With a mutation 
in the FepA outer membrane receptor, the results are anticipated be similar to Δpermease 
strains due to the inability to import and utilize the complex. Comparing the growth of 
the wild type strain of A. actinomycetemcomitans and the ΔfepA strain, results indicate 
that the ΔfepA strain is effected by the mutation.  
A. Aa Strains Supplemented with Iron Source 
 Over the course of the 48 hours that the growth curves were observed, the wild 
type strain grew on average 45.4% more than the ΔfepA strain. A repeated measure 
ANOVA (RM-ANOVA) was conducted to observe the means between the two strains. 
Overall, there was significance (p < 0.05) between the two strains with a p-value of 
0.0247. To analyze each time point, a two-way ANOVA test was also conducted, which 
confirmed significance to take place at the 4-hour (p-value = 0.007) and 24-hour (p-value 
= 0.039) mark. These results suggest that the ΔfepA strain is not as effective in acquiring 










Figure 13. Growth Curve: CDM + 100µM Fe 
 
 
B. Aa Strains Supplemented with Iron Source and Stress Hormone 
A RM-ANOVA was also conducted on the growth curves that were both 
supplemented with iron and norepinephrine. Over the course of 48 hours, there was no 
significance in the means (p-value = 0.22). To further analyze, a two-way ANOVA test 
was conducted on each of the five time points and confirmed that there was no 
significance in the variances of the samples. Although there was no significance between 
the two strains over the 48-hour period, the wild type strain grew 38.4% better than the 
ΔfepA strain, further demonstrating the important role FepA may play in iron acquisition  













Figure 11. CDM + 100 µM Fe + 50 µM Norepinephrine  
 
 
C. Aa Strains Supplemented with Loaded Iron Source, holo-Transferrin 
	 In vivo, bacteria rarely come across free iron ions. Instead, ironbound molecules 
such as lactoferrin and transferrin circulate through the blood stream. To create an 
environment similar to this, the iron source from the previous experiment was replaced 
with iron-loaded holo-Transferrin. A RM-ANOVA was conducted on the growth curve of 
wild-type strain A. actinomycetemcomitans versus the ΔfepA strain, resulting in no 
significance difference in the means (p-value = 0.28) between the two strains. To further 
analyze the data at each time point, a two-way ANOVA was also conducted to confirm 
no significance in the variation between the two strains over the course of the 48-hour 
period. This was expected, as seen in other studies [26], with no stress hormone to 
encourage the shuffling of iron bound to transferrin, neither strain of A. 











D.	Aa Strains Supplemented with Loaded Iron Source, holo-Transferrin and Stress 
Hormone	
 The stress hormone norepinephrine was then added to the environment. A RM-
ANOVA was conducted on the two strains both supplemented with holo-transferrin and 
the catecholamine norepinephrine resulting in no significance (p-value = 0.63) between 
the two strains. To further analyze the strains at each time point, a two-way ANOVA was 
conducted. It identified significance in variance at the 4-hour mark with a p-value of 
0.02, however, all other time points were not significant. Further experimentation with 
ΔfepA strains of A. actinomycetemcomitans is encouraged, but the results show that for at 
least the first twelve hours, the wild type strain was more able to thrive in that 

















Figure	13.	CDM	+	100	µM holo-Transferrin + 50 µM Norepinephrine 	
	
E.	Unloaded	Iron	Source	Control	
 A RM-ANOVA was conducted on the two environments to observe the controlled 
experiments. The two environments of CDM supplemented with 100 µM apo-Transferrin 
and CDM supplemented with both 100 µM apo- transferrin and 50 µM norepinephrine 
displayed p-values of 0.7326 and 0.7613, respectively. There was also no significance in 
the means, which was expected with a control group.  For the 36 hours that were 
recorded, both strains of A. actinomycetemcomitans grew similarly in both environments 























CDM + 100 µM apo-Transferrin













CDM + 100 µM apo-Transferrin + 50


















 The two-component system called QseBC in A. actinomycetemcomitans is 
stimulated in the presence of iron-catecholamine complexes. Without QseBC, biofilm 
growth is significantly decreased, displaying the importance the two-component system 
plays in the pathogenicity of the bacteria.    
 Bacteria are able to acquire iron through the synthesis and secretion of 
siderophores, molecules that bind to iron and bring it into the cell to be utilized. One of 
the common siderophores synthesized is enterobactin, a catechol based siderophore.  
 Studies have shown that catecholamines, such as norepinephrine, may act as 
pseudosiderophores and are able to strip iron from ironbound molecules like transferrin 
or lactoferrin. This iron-catecholamine complex can serve as a mediator for iron 
acquisition for bacteria with enterobactin acting as the final iron acceptor. However, 
those studies show that enterobactin must be present for the bacteria to be able to acquire 
the iron [26]. 
Interestingly, A. actinomycetemcomitans does not synthesize enterobactin, but 
possesses and encodes for the machinery that recognizes enterobactin and transports it 
into the cell. This lead to the hypothesis that A. actinomycetemcomitans is able to acquire 
iron through the enterobactin receptor and transporter it possesses without having to 
synthesize enterobactin itself, by stress hormone mediation. To study this, attempts were 




deletion mutation in the gene that encoded the permease of the enterobactin ABC family 
transporter. However, we encountered complications in constructing the ∆permease 
strain. After the electroporation of plasmid pJT1 into competent A. 
actinomycetemcomitans, spectinomycin resistance was observed. This suggested that 
successful insertion of the plasmid occurred into the A. actinomycetemcomitans genome 
because the plasmid codes for the resistance to spectinomycin, while wild type A. 
actinomycetemcomitans does not and pJT2 should not be maintained in the recombinant 
clones.  
Double recombination was selected for by the observation of growth in the 
presence of sucrose. Sucrose activates the SacB gene in plasmid pJT1, creating polymers 
of carbohydrates that are lethal to gram-negative bacteria. Growth did occur, as well as 
on the agar plates containing sucrose and IPTG. This phenotype suggests that a 
recombination event occurred that deleted plasmid sequences including sacB. However, 
after analyzing the sucrose resistant colonies, colony PCR indicated they had reverted 
back to wild type, but also displayed a resistance to spectinomycin they did not display 
before. The reasoning behind this phenomenon and acquiring true ∆permease strains of 
A. actinomycetemcomitans will require additional research.  
Strains of a truncated mutant strain of A. actinomycetemcomitans in the FepA 
outer membrane receptor were acquired by another student in the lab. This mutation 
should lead to an alteration in the recognition of iron-catecholamine complexes, thereby 
displaying a phenotype similar to a deletion of the permease. To study this, wild-type and 
ΔfepA strains of A. actinomycetemcomitans were inoculated into media containing free 




more difficult time growing in both environments. At some time during the study of the 
growth curve, the wild type grew significantly better than the ΔfepA strain. Although at 
other times there was no significance between the two strains, overall the wild type strain 
grew 45.4% more in CDM supplemented with iron and 38.4% more in CDM 
supplemented with both iron and norepinephrine over the 48-hour period. There are other 
systems for A. actinomycetemcomitans to acquire iron [33], however the enterobactin 
operon is the most peculiar, because of its relationship with the siderophore it doesn’t 
synthesize as mentioned above.  The growth reduction that occurred in the ΔfepA strain 
supports the hypothesis of the efficient role of the enterobactin operon in A. 
actinomycetemcomitans iron acquisition and the presence of stress hormone.  
However, free iron is not usually present in vivo. To create an environment 
similar to the oral cavity, the iron source was replaced with transferrin. Comparing the 
growth of wild type and mutant strains in the presence of just holo-Transferrin, there was 
little difference between them. This is expected, as there is no stress hormone present to 
encourage the transferrin to unload its iron content. When the stress hormone 
norepinephrine was present, there was a significant difference in growth observed in the 
first twelve hours, specifically at the 4-hour mark. This suggests that the wild-type strain 
is also able to better utilize the iron-catecholamine complexes than the ΔfepA strain.  
These results can lead to other experiments concerning the disruption of the 
enterobactin operon. A. actinomycetemcomitans is in a great position when the host 
responds to its presence with the immune response. Inflammation causes stress hormones 
to be present and cells related to the immune response such as neutrophils release 




ability to evade the immune response, the presence of both stress hormone and ironbound 
molecules puts the bacteria in a perfect position for catecholamine-mediated iron 
acquisition.   
Furthermore, the relationship between the enterobactin operon, iron acquisition 
and the two-component system QseBC can be further studied once a successful deletion 
of the permease gene is achieved. With the evidence that QseBC is activated in the 
presence of iron-catecholamine complexes and is needed for virulent properties of 
Aggregatibacter actinomycetemcomitans, studying the expression of qseBC may be the 
link between the enterobactin operon and iron acquisition. Certain genes are affected 
when QseBC is activated, with iron uptake genes down regulated. This may be because 
the bacteria has sensed an iron rich environment and diverts energy to expressing other 
useful genes, such as metabolism and respiration [21]. A rt-PCR comparing the 
expression of qseBC in wild type and Δpermease strains of A. actinomycetemcomitans in 
the presence of iron and stress hormone may reveal one of the roles of the enterobactin 
operon.  
Strains of A. actinomycetemcomitans with a disruption in the enterobactin operon 
such as ΔfepA or Δpermease strains could also be studied in a mouse model to determine 
its effect on periodontal disease. If it could be shown that the onset or degree of localized 
aggressive periodontitis is decreased, the outer membrane receptor FepA or the 
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